Intravenous iron for the treatment of iron deficiency anemia in China: a patient-level simulation model and cost-utility analysis comparing ferric derisomaltose with iron sucrose-Reference-Cited by-同舟云学术

Intravenous iron for the treatment of iron deficiency anemia in China: a patient-level simulation model and cost-utility analysis comparing ferric derisomaltose with iron sucrose

Published:2022-05-04 Issue:1 Volume:25 Page:561-570
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Hu Shanlian¹^ORCID,Liu Limin²,Pollock Richard F.³^ORCID,Pöhlmann Johannes³^ORCID,Wu Depei²,Zhang Yabing⁴

Affiliation:

1. School of Public Health, Fudan University, Shanghai, China

2. First Affiliated Hospital of Soochow University, Suzhou, China

3. Covalence Research Ltd, London, UK

4. Shanghai Institute of Technology, Shanghai, China

Funder

Pharmacosmos A/S

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2022.2065092

Reference58 articles.

1. The Global Burden of Anemia

2. Prevalence of anemia and iron deficiency anemia in Chinese pregnant women (IRON WOMEN): a national cross-sectional survey

3. Prevalence of anemia and sociodemographic characteristics among pregnant and non-pregnant women in southwest China: a longitudinal observational study

4. Yamamoto K Wang N Takita M, et al. Iron deficiency anaemia: its prevalence among women of reproductive age in Shanghai and Tokyo and links to body mass index. Cureus. 2020;12:e9436.

5. Prevalence of chronic kidney disease in China: a cross-sectional survey

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Cost-utility Analysis of Ferric Derisomaltose versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China;2024-07-11

2. Cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anemia in England;Journal of Medical Economics;2024-03-11

3. The Efficacy, Safety, and Economic Outcomes of Using Ferric Derisomaltose for the Management of Iron Deficiency in China: A Rapid Health Technology Assessment;Cureus;2023-11-13

4. Iron deficiency anemia in pregnant women;Ural Medical Journal;2023-10-27

5. Disutilities Associated with Intravenous Iron Infusions: Results from a Time Trade-off Survey and Diminishing Marginal Utility Model for Treatment Attributes in China;Patient Related Outcome Measures;2023-09